/Solventum%20Corp%20logo%20on%20phone-by%20Below%20the%20Sky%20via%20Shutterstock.jpg)
Solventum Corporation (SOLV), based in Maplewood, Minnesota, is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs. With a market cap of $12.8 billion, the company’s broad portfolio of solutions leverages material and data science, clinical research, and digital capabilities. Solventum operates in the areas of separation and purification, health information, medical solutions, medical device components, and the oral care market.
Shares of this leading global healthcare company have underperformed the broader market over the past year. SOLV has gained 4.4% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 14.5%. In 2025, SOLV stock is up 11.8%, compared to SPX’s 16.5% rise on a YTD basis.
